Antifungal activity of interleukin-2-activated natural killer (NK1.1+) lymphocytes against Candida albicans

Journal of Medical Microbiology

Volumn 47, Issue 11, 1998, Pages 1007-1014

  Mathews, H L ^a   Witek Janusek, Linda ^b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; LYMPHOCYTE ACTIVATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0031740630     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-47-11-1007     Document Type: Article

References (32)

1. Murphy JW. Mechanisms of natural resistance to human pathogenic fungi. Annu Rev Microbiol 1991; 45: 509-538.
2. Arancia G, Molinari A, Crateri P et al. Noninhibitory binding of human interleukin-2-activated natural killer cells to the germ tube forms of Candida albicans. Infect Immun 1995; 63: 280-288.
3. Beno DWA, Mathews HL. Growth inhibition of Candida albicans by interleukin-2 induced splenocytes. Infect Immun 1992; 60: 853-863.
4. Zunino SJ, Hudig D. Interactions between human natural killer (NK) lymphocytes and yeast cells: human NK cells do not kill Candida albicans, although C. albicans blocks NK lysis of K562 cells. Infect Immun 1988; 56: 564-569.
5. Blanchard DK, Michelini-Norris MB, Djeu JY. Production of granulocyte-macrophage colony-stimulating factor by large granular lymphocytes stimulated with Candida albicans: role in activation of human neutrophil function. Blood 1991; 77: 2259-2265.
6. Forsyth CB, Mathews HL. A quantitative radiometric assay to measure mammalian cell binding to hyphae of Candida albicans. J Immunol Methods 1993; 165: 113-119.
7. Djeu JY, Blanchard DK, Richards AL, Freidman H. Tumor necrosis factor induction by Candida albicans from human natural killer cells and monocytes. J Immunol 1988; 141: 4047-4052.
8. Beno DWA, Mathews HL. Growth inhibition of Candida albicans by interleukin-2-induced lymph node cells. Cell Immunol 1990; 128: 89-100.
9. + lymphocytes. J Immunol 1995; 154: 5273-5281.
10. Peace DJ, Kern DE, Schultz KR, Greenberg PD, Cheever MA. IL-4-induced lymphokines activate killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes. J Immunol 1988; 140: 3679-3685.
11. Beno DWA, Mathews HL. Quantitative measurement of lymphocyte mediated growth inhibition of Candida albicans. Immunol Methods 1993; 164: 155-164.
12. Arase H, Arase N, Nakagawa K, Good RA, Onoe K. NK1.1 + CD4 + CD8- thymocytes with specific lymphokine secretion. Eur J Immunol 1993; 23: 307-310.
13. Chong AS-F, Ybarrondo B, Grimes WJ, Hersh EM, Scuderi P. Phenotypic analyses of lymphokine-activated killer cells that release interferon (γ) and tumor necrosis factor (α). Cancer Immunol Immunother 1990; 31: 255-259.
14. Kasahara T, Djeu JY, Dougherty SF, Oppenheim JJ. Capacity of human large granular lympohcytes (LGL) to produce multiple lymphokines: interleukin 2, interferon, and colony stimulating factor. J Immunol 1983; 131: 2379-2385.
15. Marquis G, Montplaisir S, Pelletier M, Mousseau S, Auger P. Strain-dependent differenes in susceptibility of mice to experimental candidosis. J Infect Dis 1986; 154: 906-909.
16. Kalo-Klein A, Witkin SS. Prostaglandin E2 enhances and gamma interferon inhibits germ tube formation in Candida albicans. Infect Immun 1989; 58: 260-262.
17. Djeu J. Cytokines and anti-fungal immunity. In: Friedman H, Klein TW, Yamaguch H (eds) Microbial infections, role of biological response modifiers. (Advances in experimental medicine and biology, vol 319.) New York, Plenum Press, 1992: 217-223.
18. Levitz SM, North EA. Gamma interferon gene expression and release in human lympohcytes directly activated by Cryptococcus neoformans and Candida albicans. Infect Immun 1996; 64: 1595-1599.
19. Wang X, Fiscus RR, Yang L, Mathews HL. Suppression of the functional activity of IL-2 activated lymphocytes by CGRP. Cell Immunol 1995; 162: 105-113.
20. Neta R, Salvin SB. Resistance and susceptibility to infection in inbred murine strains. II. Variations in the effect of treatment with thymosin fraction 5 on the release of lymphokines in vivo. Cell Immunol 1983; 75: 173-180.
21. Marconi P, Seargini L, Tissi L et al. Induction of natural killer cell activity by inactivated Candida albicans in mice. Infect Immun 1985; 50: 297-303.
22. Scaringi L, Marconi P, Boccanera M, Tissi L, Bistoni F, Cassone A. Cell wall components of Candida albicans as immunomodulators: induction of natural killer and macrophage-mediated peritoneal cell cytotoxicity in mice by mannoprotein and glucan fractions. J Gen Microbiol 1988; 134: 1265-1274.
23. Odds FC. Pathogenesis of Candida infections. J Am Acad Dermatol 1994; 31: S2-5.
24. Lo H-J, Köhler JR, DiDomenico B, Loebenberg D, Cacciapuoti A, Fink GR. Nonfilamentous C. albicans mutants are avirulent. Cell 1997; 90: 939-949.
25. Fratti RA, Ghannoum MA, Edwards JE, Filler SG. Gamma interferon protects endothelial cells from damage by Candida albicans by inhibiting endothelial cell phagocytosis. Infect Immun 1996; 64: 4714-4718.
26. Hidore MR, Murphy JW. Murine natural killer cell interactions with a fungal target, Cryptococcus neoformans. Infect Immun 1989; 57: 1990-1997.
27. Levitz SM, Dupont MP. Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitro. J Clin Invest 1993; 91: 1490-1498.
28. Murphy JW, Hidore MR, Wong SC. Direct interactions of human lymphocytes with the yeast-like organism, Cryptococcus neoformans. J Clin Invest 1993; 91: 1553-1566.
29. Constans J, Ladner J, Dabis F et al. [CD8 hyperlymphocytosis in HIV infection; 63 cases. GECSA (Groupe d'Epidemiologie clinique du SIDA en Aquitaine).] Presse Mede 1992; 21: 27-30.
30. Warzynski MJ, Barbour SD, Winkler-Pickett RT, Ortaldo JR. CD3+, CD56+ non-MHC restricted cytotoxic T lymphocytes in two fraternal AIDS patients: a case report. Cytometry 1994; 18: 231-236.
31. Rosati E, Scaringi P, Cornacchione P et al. Cytokine response to inactivated Candida albicans in mice. Cell Immunol 1995; 162: 256-264.
32. + subset differentiation in Candida albicans-infected mice. Infect Immun 1993; 61: 3769-3774.